Bivalent Vax Protected Kids From Symptomatic COVID

(MedPage Today) -- During the 2022-2023 respiratory season, the bivalent COVID vaccines had an effectiveness of 54% against infection and 49% against symptomatic COVID in children and adolescents ages 5 to 17 years, a new study in JAMA showed...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news